Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

425 ARTÍCULOS , VIENDO DEL 196 AL 210

Effect of Levodopa on Heat Hypersensitivity and Complex Motor Parkinsonism

Noyes E, Rajput AH, Bocking S, Rajput A.

Clin Neuropharmacol. 2024 Jan-Feb 01;47(1):29-32. doi: 10.1097/WNF.0000000000000580. Epub 2023 Dec 27.

New insights on the link between Epstein‑Barr virus infection and cognitive decline in neurodegenerative diseases (Review)

Schreiner TG, Romanescu C, Schreiner OD, Nhambasora F.

Exp Ther Med. 2024 Aug 30;28(5):413. doi: 10.3892/etm.2024.12702. eCollection 2024 Nov.

Restless legs syndrome in the dominant Parkinson's side related to subthalamic deep-brain stimulation

Tordjman L, Lagha-Boukbiza O, Anheim M, Tranchant C, Bourgin P, Ruppert E.

Sleep Med. 2024 Mar;115:174-176. doi: 10.1016/j.sleep.2024.02.025. Epub 2024 Feb 13.

Characterization of de novo Dementia with Lewy Body with different duration of rapid eye movement sleep behavior disorder

Liu L, Shi Z, Gan J, Liu S, Wen C, Yang Y, Yang F, Ji Y.

Sleep Med. 2024 Feb;114:101-108. doi: 10.1016/j.sleep.2023.12.025. Epub 2023 Dec 26.

From lab bench to hope: a review of gene therapies in clinical trials for Parkinson's disease and challenges

Grote J, Patel N, Bates C, Parmar MS.

Neurol Sci. 2024 Oct;45(10):4699-4710. doi: 10.1007/s10072-024-07599-1. Epub 2024 May 25.

Parkinson's Disease Treatment: A Bibliometric Analysis

McBenedict B, Hauwanga WN, Ienaco G, Petrus D, Kazmi SS, Machado Lima J, Onabanjo BB, Felix A, Awadelseed S, Selvamani S, Cher PW, Lima Pessôa B.

Cureus. 2024 Sep 17;16(9):e69613. doi: 10.7759/cureus.69613. eCollection 2024 Sep.

Neuroprotective effects of GLP-1 class drugs in Parkinson's disease

Lv D, Feng P, Guan X, Liu Z, Li D, Xue C, Bai B, Hölscher C.

Front Neurol. 2024 Dec 10;15:1462240. doi: 10.3389/fneur.2024.1462240. eCollection 2024.

Parkinson's disease models and death signaling: what do we know until now?

Pedrão LFAT, Medeiros POS, Leandro EC, Falquetto B.

Front Neuroanat. 2024 Oct 29;18:1419108. doi: 10.3389/fnana.2024.1419108. eCollection 2024.

Practical use of DAT SPECT imaging in diagnosing dementia with Lewy bodies: a US perspective of current guidelines and future directions

O'Shea DM, Arkhipenko A, Galasko D, Goldman JG, Sheikh ZH, Petrides G, Toledo JB, Galvin JE.

Front Neurol. 2024 Apr 22;15:1395413. doi: 10.3389/fneur.2024.1395413. eCollection 2024.

Improving Healing: The Putative Effects of Low-Level Laser Therapy for Ulcer in Parkinson's Disease

Sasun AR, Phansopkar P, Qureshi MI.

Cureus. 2024 Mar 23;16(3):e56756. doi: 10.7759/cureus.56756. eCollection 2024 Mar.

Emerging Role of Long Noncoding RNAs in Regulating Inflammasome-Mediated Neurodegeneration in Parkinson's Disease

Sivagurunathan N, Rahamathulla MP, Al-Dossary H, Calivarathan L.

Mol Neurobiol. 2024 Jul;61(7):4619-4632. doi: 10.1007/s12035-023-03809-7. Epub 2023 Dec 18.

Genetics in Parkinson's disease, state-of-the-art and future perspectives

Trevisan L, Gaudio A, Monfrini E, Avanzino L, Di Fonzo A, Mandich P.

Br Med Bull. 2024 Mar 13;149(1):60-71. doi: 10.1093/bmb/ldad035.

The Role of Virtual Reality in Postural Rehabilitation for Patients with Parkinson's Disease: A Scoping Review

Agostini F, Conti M, Morone G, Iudicelli G, Fisicaro A, Savina A, Mangone M, Paoloni M.

Brain Sci. 2024 Dec 29;15(1):23. doi: 10.3390/brainsci15010023.

Approaches to Early Parkinson's Disease Subtyping

Hu M, Skjærbæk C, Borghammer P.

J Parkinsons Dis. 2024;14(s2):S297-S306. doi: 10.3233/JPD-230419.

[Commercial devices for monitoring symptoms in Parkinson's disease: benefits, limitations and trends]

Rodríguez-Martín D, Pérez-López C.

Rev Neurol. 2024 Oct 16;79(8):229-237. doi: 10.33588/rn.7908.2024253.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias